EP3541387
DOSE AND REGIMEN FOR HDM2-P53 INTERACTION INHIBITORS
:
EP einkaleyfi: Þýðing ekki lögð inn:
14.11.2017:
21.4.2021:
17804304.8
:
13.11.2037
:
DOSE AND REGIMEN FOR HDM2-P53 INTERACTION INHIBITORS
14.11.2017
21.4.2021
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
FERRETTI, Stephane:
4002 Basel, CH
:
GUERREIRO, Nelson:
4056 Basel, CH
:
JEAY, Sebastien:
4002 Basel, CH
:
JULLION, Astrid:
4056 Basel, CH
:
MEILLE, Christophe:
4056 Basel, CH
:
WUERTHNER, Jens:
4002 Basel, CH
:
201662422144 P:
15.11.2016:
US
:
201762479391 P:
31.3.2017:
US
:
IB2017057097:
14.11.2017
:
A61K 31/496, A61K 31/506, A61K 31/401, A61K 31/404, A61K 31/4418, A61K 31/4439, A61K 31/47, A61P 35/00